Answers are grounded in this paper and cite their sources.
The relevance of this study stems from the need to introduce innovative treatment methods into pediatric clinical practice—methods that can improve the quality of life for young patients (including by reducing pain) and enable young athletes to return to training and competition as quickly as possible, with minimal adverse effects. One such method is platelet-rich plasma (PRP), which is widely used for joint conditions in the adult population, including professional athletes; however, data on its use in children and adolescents remain limited. The objective of this study was to evaluate the efficacy of platelet-rich plasma in adolescent athletes with injuries and damage to major joints. Materials and Methods. The study included two groups of adolescent athletes: an experimental group (n = 38) that received a course of PRP treatment, and a control group (n = 38) that received conventional conservative treatment. Assessments included pain intensity (using the Visual Analog Scale, VAS), muscle strength (based on the Hislop and Montgomery classification), and magnetic resonance imaging (MRI) findings. Statistical data processing was performed using MedStat.Pro v1.1.5, JASP v0.16, and Microsoft Excel (Data Analysis Toolpak). Qualitative variables are presented as proportions (%) with 95 % confidence intervals. Within-group comparisons were conducted using the Wilcoxon signed-rank test, with a critical significance level set at ≤0.05. Correlation analysis (Spearman’s rank correlation) was used to examine relationships between quantitative variables. Pearson’s chi-squared (χ²) test was employed to analyze contingency tables and compare the frequencies of qualitative variables between the experimental and control groups. Results. It was demonstrated that a course of PRP therapy exerts a pronounced analgesic effect; a statistically significant (p < 0.001) reduction in pain was observed following the first injection (from 5.00 [5.00; 6.00] to 4.00 [3.00; 4.00] points on the Visual Analog Scale [VAS]), with the maximum effect (0.00 [0.00; 1.00] points on the VAS) achieved after the third injection. Twelve weeks after the initial PRP injection, a persistent inverse correlation was identified between the reduction in pain and an increase in muscle strength (r = -0.619; p < 0.001). MRI assessments revealed structural improvements in the affected area; a follow-up evaluation after the course of PRP therapy showed a 3.86-fold decrease in the number of MRI signs of traumatic injury. Conclusion. PRP therapy helps alleviate pain after just the first injection and facilitates deeper, long-term structural recovery of damaged tissues (continuing for at least 12 weeks following a full course of treatment). Due to its autologous nature, the risk of adverse reactions is low.
No takes yet. Share an insight, caveat, or question.
Zavaleva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: